Filter
322
Filtered Results: 322
Text search:
opoids
Featured
Recommendations
45
New Publications
72
Language
Document type
No document type
175
Guidelines
58
Studies & Reports
40
Manuals
26
Strategic & Response Plan
8
Training Material
6
Fact sheets
6
Situation Updates
1
Resource Platforms
1
Infographics
1
Countries / Regions
India
21
Kenya
14
Global
11
Western and Central Europe
10
Ukraine
9
Eastern Europe
6
Russia
6
Ethiopia
6
Liberia
6
Africa
4
Asia
4
Tanzania
4
South–East Asia Region
4
Nepal
3
South Africa
3
Uganda
3
Georgia
3
Myanmar / Burma
3
North Macedonia
2
Tajikistan
2
Thailand
2
Rwanda
2
Nigeria
2
Senegal
2
Kyrgyzstan
2
Middle East and North Africa
2
Eastern Europe and Central Asia
2
East and Southern Africa
2
Argentina
2
Bangladesh
2
Colombia
1
Mexico
1
Serbia
1
Ghana
1
Benin
1
Sierra Leone
1
Kazakhstan
1
Syria
1
Albania
1
Canada
1
Estonia
1
Morocco
1
Mozambique
1
Haiti
1
Cambodia
1
Latin America and the Carribbean
1
Hungary
1
Western Pacific Region
1
Jamaica
1
Norway
1
Portugal
1
Southern Africa
1
Lebanon
1
Vietnam
1
Brazil
1
Moldova
1
Namibia
1
Poland
1
Libya
1
Bhutan
1
Zambia
1
Indonesia
1
Solomon Islands
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Countries
82
Clinical Guidelines
60
Women & Child Health
18
Public Health
16
Key Resources
4
Capacity Building
1
Toolboxes
Mental Health
95
HIV
56
Pharmacy
30
Caregiver
21
TB
7
COVID-19
6
NCDs
6
Conflict
4
AMR
4
Social Ethics
3
Rapid Response
1
Natural Hazards
1
Ebola & Marburg
1
The guidance document provides a set of indicators for assessing the status of development, implementation and monitoring of key policy interventions for prevention and control of NCDs and injuries. It promotes city-level evidence based decision-making processes to identify gaps and take appropriate...
WHO’s Essential Medicines List and List of Essential Diagnostics are core guidance documents that help countries prioritize critical health products that should be widely available and affordable throughout health systems. The updated Essential Medicines List adds 23 medicines for children.
AIDSTAR-One | CASE STUDY SERIES November 2012
The World Drug Report 2022 is aimed not only at fostering greater international cooperation to counter the impact of the world drug problem on health, governance and security, but also, with its special insights, at assisting Member States in anticipating and address-ing threats from drug markets an...
Primary Care: The Community Health System
Ramped-up cancer services could save 7 million lives over the next decade—and addressing huge service gaps between rich and poor countries is key to success, according to this report.
In 2019, over 90% of high-income countries reported that comprehensive cancer treatment services were available...
Guidelines
Key Populations
Cancer
recommended
This volume presents the complex patterns of cancer incidence and death around the world and evidence on effective and cost-effective ways to control cancers. The Disease Control Priorities Volume 3 evaluation of cancer will indicate where cancer treatment is ineffective and wasteful, and offer alte...
Updated 10 August 2020
This document presents an essential medicines list (EML) to manage patients in intensive care units (ICUs) with suspected or confirmed COVID-19 diagnosis, which includes active ingredients with dosage form and concentration, and are preferably in the WHO Model Lists of Essent...
Joint United Nations Programme on HIV/AIDS
Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection
Accessed: 26.02.2020
The second edition of the WHPCA Global Atlas of Palliative Care was launched during World Hospice & Palliative Care Day 10 October. The Atlas is an update of the original WHPCA/WHO Global Atlas of Palliative care at the end of life published in 2014. It is full of useful facts and figures to support...
Policy Brief
Consolidated Guidelines
Updated 2016
WHO/HIV/2017.05
This publication provides managers with guidance on how to create basic HIV prevention cascades as a starting point to enhance their ability to monitor and improve their programming and to facilitate comparisons of programme effectiveness across sites.
